{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T03:42:26Z","timestamp":1769312546487,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T00:00:00Z","timestamp":1463616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health & Welfare","award":["HI13C-2098-030013"],"award-info":[{"award-number":["HI13C-2098-030013"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2014M3A9D5A01073598"],"award-info":[{"award-number":["2014M3A9D5A01073598"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004082","name":"Korean Foundation for Cancer Research","doi-asserted-by":"publisher","award":["CB2011-02-01"],"award-info":[{"award-number":["CB2011-02-01"]}],"id":[{"id":"10.13039\/501100004082","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jprot.2016.04.052","type":"journal-article","created":{"date-parts":[[2016,5,8]],"date-time":"2016-05-08T15:53:00Z","timestamp":1462722780000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Meta-markers for the differential diagnosis of lung cancer and lung disease"],"prefix":"10.1016","volume":"148","author":[{"given":"Yong-In","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3769-9770","authenticated-orcid":false,"given":"Jung-Mo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Jin","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Su","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaesung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongdai","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1030-3577","authenticated-orcid":false,"given":"Je-Yoel","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jprot.2016.04.052_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"Ca-Cancer J. Clin."},{"key":"10.1016\/j.jprot.2016.04.052_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(99)06093-6","article-title":"Early lung cancer action project: overall design and findings from baseline screening","volume":"354","author":"Henschke","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jprot.2016.04.052_bb0015","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1056\/NEJMcp012290","article-title":"Clinical practice. The solitary pulmonary nodule","volume":"348","author":"Ost","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jprot.2016.04.052_bb0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nature06916","article-title":"Mining the plasma proteome for cancer biomarkers","volume":"452","author":"Hanash","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jprot.2016.04.052_bb0025","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/ncponc1187","article-title":"Strategies for discovering novel cancer biomarkers through utilization of emerging technologies","volume":"5","author":"Kulasingam","year":"2008","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.jprot.2016.04.052_bb0030","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.biopha.2007.08.005","article-title":"Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer","volume":"61","author":"Cho","year":"2007","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jprot.2016.04.052_bb0035","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrc1739","article-title":"Biomarkers in cancer staging, prognosis and treatment selection","volume":"5","author":"Ludwig","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jprot.2016.04.052_bb0040","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nbt.1546","article-title":"Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma","volume":"27","author":"Addona","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jprot.2016.04.052_bb0045","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1074\/mcp.M900140-MCP200","article-title":"Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution","volume":"8","author":"Keshishian","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jprot.2016.04.052_bb0050","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1074\/mcp.M800540-MCP200","article-title":"Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma","volume":"8","author":"Kuzyk","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jprot.2016.04.052_bb0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nmeth.2309","article-title":"Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry","volume":"10","author":"Gillette","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jprot.2016.04.052_bb0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1378\/chest.97.3.639","article-title":"Clinical significance of a multiple biomarker assay in patients with lung cancer. A study with logistic regression analysis","volume":"97","author":"Lombardi","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.jprot.2016.04.052_bb0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1074\/mcp.M113.028621","article-title":"Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer","volume":"13","author":"Ahn","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jprot.2016.04.052_bb0070","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1074\/mcp.M900398-MCP200","article-title":"Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas","volume":"9","author":"Wu","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jprot.2016.04.052_bb0075","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1373\/clinchem.2009.128058","article-title":"Protein quantification by mass spectrometry: is it ready for prime time?","volume":"55","author":"Diamandis","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jprot.2016.04.052_bb0080","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.bbapap.2013.06.008","article-title":"Advances in multiplexed MRM-based protein biomarker quantitation toward clinical utility","volume":"1844","author":"Percy","year":"2014","journal-title":"Biochim. Biophys. Acta, Proteins and Proteomics"},{"key":"10.1016\/j.jprot.2016.04.052_bb0085","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jprot.2010.12.006","article-title":"Developments for a growing Japanese patient population: facilitating new technologies for future health care","volume":"74","author":"Kato","year":"2011","journal-title":"J. Proteomics."},{"key":"10.1016\/j.jprot.2016.04.052_bb0090","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1373\/clinchem.2008.114686","article-title":"Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory?","volume":"54","author":"Carr","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jprot.2016.04.052_bb0095","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1074\/mcp.M112.022442","article-title":"Multiplexed quantitation of endogenous proteins in dried blood spots by multiple reaction monitoring-mass spectrometry","volume":"12","author":"Chambers","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jprot.2016.04.052_bb0100","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0022-2143(96)90152-3","article-title":"Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease","volume":"127","author":"Chao","year":"1996","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.jprot.2016.04.052_bb0105","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0022-2275(20)33445-3","article-title":"A sandwich enzyme-linked immunosorbent assay for human serum paraoxonase concentration","volume":"41","author":"Kujiraoka","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jprot.2016.04.052_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/ac9509519","article-title":"Analytical properties of the nanoelectrospray ion source","volume":"68","author":"Wilm","year":"1996","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jprot.2016.04.052_bb0115","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/jnci\/djq306","article-title":"Cancer biomarkers: can we turn recent failures into success?","volume":"102","author":"Diamandis","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jprot.2016.04.052_bb0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1373\/clinchem.2012.184903","article-title":"Is early detection of cancer with circulating biomarkers feasible?","volume":"59","author":"Konforte","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jprot.2016.04.052_bb0125","first-page":"w13801","article-title":"Potentials and pitfalls of clinical peptidomics and metabolomics","volume":"143","author":"Leichtle","year":"2013","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.jprot.2016.04.052_bb0130","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood-2013-06-510586","article-title":"Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease","volume":"122","author":"Xiao","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jprot.2016.04.052_bb0135","article-title":"Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jprot.2016.04.052_bb0140","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Team NLSTR","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jprot.2016.04.052_bb0145","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.mol.0000174398.84185.0f","article-title":"Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences","volume":"16","author":"Aviram","year":"2005","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jprot.2016.04.052_bb0150","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1158\/1535-7163.MCT-06-0798","article-title":"Kallikrein-binding protein inhibits growth of gastric carcinoma by reducing vascular endothelial growth factor production and angiogenesis","volume":"6","author":"Zhu","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jprot.2016.04.052_bb0155","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/art.20991","article-title":"Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation","volume":"52","author":"Wang","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jprot.2016.04.052_bb0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/hum.1997.8.3-341","article-title":"Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats","volume":"8","author":"Chen","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jprot.2016.04.052_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1172\/JCI119502","article-title":"Kallistatin is a potent new vasodilator","volume":"100","author":"Chao","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jprot.2016.04.052_bb0170","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood-2002-01-0185","article-title":"Kallistatin is a new inhibitor of angiogenesis and tumor growth","volume":"100","author":"Miao","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jprot.2016.04.052_bb0175","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00524.2002","article-title":"Structural elements of kallistatin required for inhibition of angiogenesis","volume":"284","author":"Miao","year":"2003","journal-title":"Am. J. Physiol.-Cell Ph."},{"key":"10.1016\/j.jprot.2016.04.052_bb0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2407-10-245","article-title":"Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin","volume":"10","author":"Shiau","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jprot.2016.04.052_bb0185","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jprot.2016.04.052_bb0190","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1074\/mcp.M113.028621","article-title":"Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer","volume":"13","author":"Ahn","year":"2014","journal-title":"Mol. Cell. Proteomics."},{"key":"10.1016\/j.jprot.2016.04.052_bb0195","first-page":"679","article-title":"Assessment of serum paraoxonase and arylesterase activity in patients with endometrial cancer","volume":"30","author":"Arioz","year":"2009","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.jprot.2016.04.052_bb0200","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ygyno.2008.10.031","article-title":"Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer","volume":"112","author":"Camuzcuoglu","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jprot.2016.04.052_bb0205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2407-7-48","article-title":"Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population","volume":"7","author":"Elkiran","year":"2007","journal-title":"BMC Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.jprot.2016.04.052_bb0210","first-page":"cclxxiii","article-title":"Serum paraoxonase levels in gastric cancer","volume":"50","author":"Akcay","year":"2003","journal-title":"Hepato-gastroenterology"},{"key":"10.1016\/j.jprot.2016.04.052_bb0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pathophys.2010.05.002","article-title":"Serum paraoxonase and arylesterase activities in patients with pulmonary tuberculosis","volume":"18","author":"Naderi","year":"2011","journal-title":"Pathophysiology"}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391916301841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391916301841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T16:38:30Z","timestamp":1655743110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874391916301841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":43,"alternative-id":["S1874391916301841"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2016.04.052","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-markers for the differential diagnosis of lung cancer and lung disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jprot.2016.04.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}